Diffuse panbronchiolitis in China

@article{Chen2005DiffusePI,
  title={Diffuse panbronchiolitis in China},
  author={Yu Chen and Jian Kang and Shengqi Li},
  journal={Respirology},
  year={2005},
  volume={10}
}
Objective:  Diffuse panbronchiolitis (DPB) is a progressive inflammatory disease, well recognized in Japan, that is characterized by chronic sinusitis and obstructive small airway disease. A total of 40 patients with DPB in mainland China were reviewed in order to describe the epidemiology of DPB in China and to compare their clinical characteristics with those of cases reported in Japan. 

Good's syndrome with diffuse panbronchiolitis as the prominent manifestation: A case and literature review

It is indicated that in adults with DPB‐like clinical manifestations, thymic lesions should be excluded and related immune function tests should be performed to exclude GS to avoid missed diagnosis and misdiagnosis.

Clinical profiles of 12 Chinese patients with diffuse panbronchiolitis.

More DPB cases need to be analyzed from Chinese population due to different presentations compared to Japanese population and this experience should help other clinicians in the investigation and management of DPB in non-Japanese patients.

Diffuse panbronchiolitis in East Asia

A new anti‐inflammatory analogue without antimicrobial activity should be developed to minimize the emergence of macrolide‐resistant microorganisms and to maintain the safety of this treatment.

Noninfectious Inflammatory Small Airways Diseases

CT features of inflammatory bronchiolitis may also be found with diffuse lung disease such as hypersensitivity pneumonitis, sarcoidosis, or Langerhans histiocytosis, and with collagen vascular disease or inflammatory bowel disease.

Diffuse Panbronchiolitis: Long-Term Low-Dose Macrolide Therapy

The history of the development of long-term low-dose macrolide therapy for DPB, and the mechanisms by which this therapy exerts its clinical benefits are introduced.

Effect of azithromycin on patients with diffuse panbronchiolitis: retrospective study of 51 cases.

Azithromycin is effective and well tolerated for patients with diffuse panbronchiolitis and is eliminated to certain degrees for the other 36 cases of DPB.

Differential association between HLA and diffuse panbronchiolitis in Northern and Southern Chinese.

HLA-B54 and HLA-A11 were positively associated with DPB in Northern and Southern Chinese, respectively.

A rare lung disease in an Indian man

CASE REPORT A 20-year-old man of Indian ethnicity presented with a productive cough of 4 years duration which had gradually worsened such that, immediately prior to presentation, he produced up to a

References

SHOWING 1-10 OF 19 REFERENCES

Diffuse Panbronchiolitis in North America: Report of Three Cases and Review of the Literature

Two cases occurring in white patients and one in an Oriental immigrant to Canada are presented, characterized by a suppurative bronchiolitis involving primarily the respiratory and terminal Bronchioles with subsequent progression to bronchiolectasis.

Diffuse panbronchiolitis in an Asian immigrant.

The known efficacy of low dose erythromycin in DPB was again confirmed after failure of long term high dose corticosteroid therapy administered before an accurate diagnosis had been made.

Diffuse panbronchiolitis in a Hispanic man with travel history to Japan.

The patient had an extensive travel history to the Far East, including Japan, and this case raises the possibility of a poorly transmissible infectious agent responsible for the disease.

The first report of diffuse panbronchiolitis in Korea: five case reports.

In three clinically and radiologically suspected cases, high resolution computed tomography showed the typical findings of DPB and other diseases such as pulmonary emphysema, bronchial asthma, chronic bronchitis and bronchiectasis could be ruled out.

Recurrence of diffuse panbronchiolitis after lung transplantation.

The occurrence of a case of DPB in an African American patient who underwent bilateral sequential lung transplantation is described, with rapid and significant deterioration in graft function ten weeks after transplantation.

Clinical profiles of Chinese patients with diffuse panbronchiolitis

The only series of non-Japanese Mongoloid patients with well characterised DPB who had uncharacteristic investigation profiles are reported and should help other clinicians in the investigation and management of DPB in non- Japanese patients.

[Clinicopathological analysis of 6 cases of diffuse panbronchiolitis].

  • H. LiuT. LiuH. Ren
  • Medicine
    Zhonghua bing li xue za zhi = Chinese journal of pathology
  • 2001
Diffuse panbronchiolitis is a distinct clinicopathological entity and open lung biopsy or thorocoscopic biopsy is necessary for the correct diagnosis of clinical atypical DPB cases.

Diffuse panbronchiolitis. A disease of the transitional zone of the lung.

Diffuse panbronchiolitis belongs to a distinctly different category from these diseases, and should be distinguished from them, because it may often show rapid progression with fatal outcome.

Analysis of HLA antigens in patients with diffuse panbronchiolitis.

HLA analysis of patients with diffuse panbronchiolitis found that Bw54, or its related haplotype, exists only in Japanese, Chinese, and Korean populations, which suggests that one or some of the genes controlling the susceptibility and/or immune responsiveness of diffusePanbronChiolitis might be located near HLA loci.

Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin.

The efficacy of EM treatment increased the survival rate of patients with DPB, which was more significant in the older than in the younger patients, and a significant difference in the survival rates between the two subgroups in Group c (p < 0.001).